---
figid: PMC4140952__nihms587192f1
figlink: /pmc/articles/PMC4140952/figure/F1/
number: Fig. 1
caption: 'A schematic representation of cPAcP interaction with HER-2 and PI3K/Akt
  pathway in regulating prostate cell homeostasis. cPAcP loss of expression induces
  carcinogenesis and subsequently prostate cancer (PCa) cell proliferation and progression.
  Initiation of PCa is accompanied by an early decrease of cPAcP expression in prostate
  cells resulting in hyperphosphorylation of HER-2 on tyrosine residues including
  Y1221/2 and Y1248. In addition to the activation of HER-2/MAPK pathway, loss of
  cPAcP activity can lead to the accumulation of PIP3 and subsequent Akt activation,
  which results in PCa progression and survival. Akt activation can phosphorylate
  S6K and GSK3 and leads to prostate cell proliferation. Activated Akt may phosphorylate
  and sequester FKHR and BAD in cytoplasm which results in survival of PCa cells.
  In addition, Akt may also phosphorylate AR and ERK which results in inducing PCa
  cell proliferation. Abbreviations: Akt, v-akt murine thymoma viral oncogene homolog;
  AR, androgen receptor; BAD, Bcl-2-associated death promoter protein; cPAcP, cellular
  prostatic acid phosphatase; ERK, extracellular signal-regulated kinases; FKHR, forkhead
  in rhabdomyosarcoma (also designated FOXO1); GSK3, glycogen synthase kinase 3; HER-2,
  human epidermal growth factor receptor-2 (also designated ErbB-2/neu); PDK-1, phosphoinositide-dependent
  kinase 1; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol
  3,4,5-trisphosphate; S6K, ribosomal S6 kinase (a family member of serine/threonine
  kinases).'
pmcid: PMC4140952
papertitle: Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate
  epithelia, functions as a prostate-specific tumor suppressor.
reftext: Sakthivel Muniyan, et al. Biochim Biophys Acta. ;1846(1):88-98.
pmc_ranked_result_index: '177980'
pathway_score: 0.9781272
filename: nihms587192f1.jpg
figtitle: CPAcP interaction with HER-2 and PI3K/Akt pathway in regulating prostate
  cell homeostasis
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4140952__nihms587192f1.html
  '@type': Dataset
  description: 'A schematic representation of cPAcP interaction with HER-2 and PI3K/Akt
    pathway in regulating prostate cell homeostasis. cPAcP loss of expression induces
    carcinogenesis and subsequently prostate cancer (PCa) cell proliferation and progression.
    Initiation of PCa is accompanied by an early decrease of cPAcP expression in prostate
    cells resulting in hyperphosphorylation of HER-2 on tyrosine residues including
    Y1221/2 and Y1248. In addition to the activation of HER-2/MAPK pathway, loss of
    cPAcP activity can lead to the accumulation of PIP3 and subsequent Akt activation,
    which results in PCa progression and survival. Akt activation can phosphorylate
    S6K and GSK3 and leads to prostate cell proliferation. Activated Akt may phosphorylate
    and sequester FKHR and BAD in cytoplasm which results in survival of PCa cells.
    In addition, Akt may also phosphorylate AR and ERK which results in inducing PCa
    cell proliferation. Abbreviations: Akt, v-akt murine thymoma viral oncogene homolog;
    AR, androgen receptor; BAD, Bcl-2-associated death promoter protein; cPAcP, cellular
    prostatic acid phosphatase; ERK, extracellular signal-regulated kinases; FKHR,
    forkhead in rhabdomyosarcoma (also designated FOXO1); GSK3, glycogen synthase
    kinase 3; HER-2, human epidermal growth factor receptor-2 (also designated ErbB-2/neu);
    PDK-1, phosphoinositide-dependent kinase 1; PIP2, phosphatidylinositol 4,5-bisphosphate;
    PIP3, phosphatidylinositol 3,4,5-trisphosphate; S6K, ribosomal S6 kinase (a family
    member of serine/threonine kinases).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FLVCR1
  - BRAF
  - PIK3CA
  - AKT3
  - PIK3CG
  - PIK3R3
  - AKT2
  - PIK3R5
  - PIK3CB
  - PIK3CD
  - PIK3R6
  - GSK3A
  - MAP2K2
  - MTOR
  - FOXO1
  - MLST8
  - MAPKAP1
  - HRAS
  - PDK1
  - AR
  - BAD
  - PIK3R4
  - MAPK3
  - ARAF
  - RAF1
  - GSK3B
  - ERBB2
  - AKT1
  - NRAS
  - RICTOR
  - MAPK1
  - MAP2K1
  - KRAS
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PCa
  symbol: PCA
  source: hgnc_alias_symbol
  hgnc_symbol: FLVCR1
  entrez: '28982'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: -MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FKHR
  symbol: FKHR
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: -MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: -MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: HER-2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: -MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
